Searched for
MARC KIKUCHI
Glenmark Pharmaceuticals wins USFDA nod for fluticasone inhalerGlenmark Pharmaceuticals has secured a significant approval from the US FDA for its inhaler fluticasone propionate. This marks a key step i...- Glenmark launches generic cancer treatment drug in USGlenmark Pharmaceuticals on Tuesday launched Eribulin Mesylate Injection, a generic cancer treatment, in the US through its subsidiary Glen...
- Glenmark acquires Acetylcysteine injection, launches in US marketGlenmark Pharmaceuticals Ltd acquired the generic version of Acetylcysteine injection from Aspen Pharma USA Inc and launched it in the US m...
- Glenmark launches Epinephrine injection in USGlenmark Pharmaceuticals has launched a generic version of Epinephrine injection multiple-dose vial in the US, gaining 180 days of CGT excl...
- Glenmark launches generic ophthalmic solution in US marketGlenmark Pharmaceuticals' subsidiary has introduced Latanoprost ophthalmic solution, a generic medication for glaucoma, in the US market. T...
- Glenmark launches generic anticoagulant injectable emulsionGlenmark Pharmaceuticals has launched Phytonadione injectable emulsion through its US arm, targeting anticoagulant markets. The 10 mg/mL si...
- Dr Reddy's acquires MenoLabs' women health brands in USDr. Reddy’s acquired the entire MenoLabs supplements portfolio which includes seven branded products to treat perimenopause and menopause. ...
- Dr Reddy's to acquire Mayne Pharma US generic portfolio for $105 millionUnder the terms of the agreement, Dr. Reddy’s will acquire the portfolio for an upfront payment of $90 million in cash, contingent payments...
- Dr Reddy's launches generic Revlimid in US market"We are pleased with the first-to-market launch of two of our six strengths of Lenalidomide Capsules with 180-day market exclusivity. Bring...
- DRL acquires injectable portfolio from US-based Eton Pharma for $50 millionThe portfolio includes the Biorphen (phenylephrine hydrocholoride) injection and Rezipres (ephedrine hydrochloride) injection NDAs (new dru...
- Dr Reddy's launches authorised generic of Vasostrict injection“We are pleased to provide this important authorized generic product to patients, especially in these difficult times of COVID-19,” says Ma...
- Dr Reddy's gets FDA nod for generic Revlimid; enjoys 180 days exclusivity"We are pleased with the Agency's approval of Lenalidomide Capsules, 2.5 mg and 20 mg and being eligible for 180-day market exclusivity. We...
- Dr Reddy's launches generic Invanz injection in US marketWe're excited to extend our strategic partnership with Gland Pharma whose hard work, in collaboration with the team at Dr Reddys, has enabl...
- Dr Reddy's launches generic epilepsy drug in US market"We are pleased that this product has been designated as a Competitive Generic Therapy (CGT) by the FDA," Dr Reddy's Laboratories North Ame...
- Dr Reddy's Laboratories launches over-the-counter eye allergy drop in USDr Reddy's said Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2 per cent and 0.1 per cent, are indicated for the temporary relief of...
- Dr Reddy's launches generic arthritis drug in US market"The launch of product is an important addition to our pain/analgesics portfolio of over-the-counter (OTC) products, and represents our con...
- Dr Reddy's Labs launches generic injection indicated for abortion in USThe company has launched Carboprost Tromethamine injection USP, 250 mcg/mL (1mL) single-dose vial in the US market, the pharma major said i...
- Dr Reddy's re-launches generic version of Suboxone in US marketIndivior is in a legal battle against the launch of the copycat version of its opioid addiction treatment by competitors.
Load More
